Page last updated: 2024-11-03

prazosin and Lupus Erythematosus, Systemic

prazosin has been researched along with Lupus Erythematosus, Systemic in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chatterjee, K1
Massie, B1
Rubin, S1
Gelberg, H1
Brundage, BH1
Ports, TA1
Feurle, GE1

Other Studies

2 other studies available for prazosin and Lupus Erythematosus, Systemic

ArticleYear
Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    The American journal of medicine, 1978, Volume: 65, Issue:1

    Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Hemodynamics; Humans; H

1978
[Doxazosin-induced lupus erythematodes].
    Deutsche medizinische Wochenschrift (1946), 1992, Jan-24, Volume: 117, Issue:4

    Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Doxazosin; Female; Humans; Lupus Erythematosu

1992